Dasatinib, High-Dose Imatinib And Nilotinib In Chinese Patients With Chronic Phase Of Chronic Myeloid Leukemia With Imatinib-Resistance Or -Intoleran An Economic Evaluation
Abstract
Authors
B Wu
B Wu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now